Swiss Re’s Colgate-Palmolive CL Stock Holding History

Swiss Re’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$14.9K	Hold	175	–	–	0.09%	173
2025 Q4	$13.8K	Buy	+175	New	+$13.7K	﹤0.01%	182

Other funds holding CL

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

DAM

Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Swiss Re's CL Position: Q1 2026 in Review

Swiss Re held its Colgate-Palmolive (CL) position steady in Q1 2026 at 175 shares worth $14.9K. The position accounts for 0.09% of the portfolio, ranked #173.

Swiss Re first reported a position in CL in Q4 2025 and has held it in 2 quarters since. 1,947 funds tracked by Wall St. Rank hold CL as of Q1 2026.

Swiss Re held 175 shares of Colgate-Palmolive worth $14.9K as of Q1 2026.
Swiss Re left its Colgate-Palmolive share count unchanged in Q1 2026.
Colgate-Palmolive made up 0.09% of Swiss Re's portfolio in Q1 2026, its #173 holding.
Swiss Re first reported a position in Colgate-Palmolive in Q4 2025 and has held it in 2 quarters since.
1,947 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Swiss Re's 13F filing for Q1 2026, filed 12 May 2026.